145 related articles for article (PubMed ID: 1694851)
21. Murine monoclonal antibodies to human factor XI.
Nishikado H; Komiyama Y; Masuda M; Egawa H; Murata K
Thromb Res; 1986 Apr; 42(2):225-34. PubMed ID: 3487138
[TBL] [Abstract][Full Text] [Related]
22. Localization of the high molecular weight kininogen binding site in the heavy chain of human factor XI to amino acids phenylalanine 56 through serine 86.
Baglia FA; Jameson BA; Walsh PN
J Biol Chem; 1990 Mar; 265(7):4149-54. PubMed ID: 2105959
[TBL] [Abstract][Full Text] [Related]
23. Immunovisualisation of plasma prekallikrein and H-kininogen on human neutrophils and in human hepatocytes.
Henderson LM; Figueroa CD; Muller-Esterl W; Stain A; Bhoola KD
Agents Actions Suppl; 1992; 38 ( Pt 1)():590-4. PubMed ID: 1466300
[TBL] [Abstract][Full Text] [Related]
24. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains.
Schmaier AH; Schutsky D; Farber A; Silver LD; Bradford HN; Colman RW
J Biol Chem; 1987 Jan; 262(3):1405-11. PubMed ID: 2433279
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
Griffin JH; Cochrane CG
Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
[TBL] [Abstract][Full Text] [Related]
26. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
[TBL] [Abstract][Full Text] [Related]
27. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
Bock PE; Shore JD; Tans G; Griffin JH
J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
[TBL] [Abstract][Full Text] [Related]
28. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.
Scott CF; Colman RW
J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688
[TBL] [Abstract][Full Text] [Related]
29. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
Mandle RJ; Colman RW; Kaplan AP
Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
[TBL] [Abstract][Full Text] [Related]
30. Immunological characterization of rat kininogens with monoclonal antibodies to T-kininogen. Distinction between the different domains of T-kininogen and the multiple rat kininogens.
Lesage S; Bouhnik J; Richoux JP; Baussant T; Gauthier F; Eager K; Corvol P; Alhenc-Gelas F
Eur J Biochem; 1992 Mar; 204(2):501-8. PubMed ID: 1541265
[TBL] [Abstract][Full Text] [Related]
31. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
Sugi T; McIntyre JA
J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858
[TBL] [Abstract][Full Text] [Related]
32. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI.
Tait JF; Fujikawa K
J Biol Chem; 1987 Aug; 262(24):11651-6. PubMed ID: 3650269
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor.
Kaplan AP; Silverberg M; Dunn JT; Miller G
Ann N Y Acad Sci; 1981; 370():253-60. PubMed ID: 6455951
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.
Renné T; Gailani D; Meijers JC; Müller-Esterl W
J Biol Chem; 2002 Feb; 277(7):4892-9. PubMed ID: 11733491
[TBL] [Abstract][Full Text] [Related]
35. Identification of the binding site for plasma prekallikrein in human high molecular weight kininogen. A region from residues 185 to 224 of the kininogen light chain retains full binding activity.
Tait JF; Fujikawa K
J Biol Chem; 1986 Nov; 261(33):15396-401. PubMed ID: 3096985
[TBL] [Abstract][Full Text] [Related]
36. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization.
Shimada T; Kato H; Maeda H; Iwanaga S
J Biochem; 1985 Jun; 97(6):1637-44. PubMed ID: 3928613
[TBL] [Abstract][Full Text] [Related]
37. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
Ratnoff OD; Saito H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor.
Herwald H; Dedio J; Kellner R; Loos M; Müller-Esterl W
J Biol Chem; 1996 May; 271(22):13040-7. PubMed ID: 8662673
[TBL] [Abstract][Full Text] [Related]
39. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
[TBL] [Abstract][Full Text] [Related]
40. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
Imamura T; Dubin A; Moore W; Tanaka R; Travis J
Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
